Recent advancements in diabetes therapy have introduced a new class of drugs known as GLP-1 receptor agonists. These medications, which mimic the effects of a naturally occurring hormone called glucagon-like peptide-1 https://roxannulin256110.qodsblog.com/38975121/novel-therapeutics-for-diabetes-management